Optimizing Natural Products by Biosynthetic Engineering: Discovery of Nonquinone Hsp90 Inhibitors

Journal of Medicinal Chemistry
2008.0

Abstract

A biosynthetic medicinal chemistry approach was applied to the optimization of the natural product Hsp90 inhibitor macbecin. By genetic engineering, mutants have been created to produce novel macbecin analogues including a nonquinone compound (5) that has significantly improved binding affinity to Hsp90 (Kd 3 nM vs 240 nM for macbecin) and reduced toxicity (MTD > or = 250 mg/kg). Structural flexibility may contribute to the preorganization of 5 to exist in solution in the Hsp90-bound conformation.

Knowledge Graph

Similar Paper

Optimizing Natural Products by Biosynthetic Engineering: Discovery of Nonquinone Hsp90 Inhibitors
Journal of Medicinal Chemistry 2008.0
Molecular Characterization of Macbecin as an Hsp90 Inhibitor
Journal of Medicinal Chemistry 2008.0
Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative Agents
Journal of Medicinal Chemistry 2011.0
C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity
Bioorganic & Medicinal Chemistry Letters 2016.0
Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone
Journal of Medicinal Chemistry 2010.0
Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity
Bioorganic & Medicinal Chemistry Letters 2011.0
New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus
The Journal of Antibiotics 2011.0
Potent Non-Benzoquinone Ansamycin Heat Shock Protein 90 Inhibitors from Genetic Engineering of <i>Streptomyces hygroscopicus</i>
Journal of Medicinal Chemistry 2009.0
Potent Non-Benzoquinone Ansamycin Heat Shock Protein 90 Inhibitors from Genetic Engineering of <i>Streptomyces hygroscopicus</i>
Journal of Medicinal Chemistry 2009.0
Synthesis and Evaluation of Noviose Replacements on Novobiocin That Manifest Antiproliferative Activity
ACS Medicinal Chemistry Letters 2010.0